Literature DB >> 3826130

Persistent adrenal insufficiency secondary to low-dose ketoconazole therapy.

T R Best, J K Jenkins, F Y Murphy, S A Nicks, K L Bussell, D L Vesely.   

Abstract

Persistent adrenal insufficiency secondary to ketoconazole therapy has not previously been documented. A case of adrenocortical insufficiency secondary to low-dose (400 mg per day) ketoconazole therapy for blastomycosis is described. Symptomatic adrenal insufficiency was documented on endocrine testing, required physiologic replacement doses of glucocorticoids, and has not been reversible in two years of follow-up. Thus, adrenal insufficiency may be caused by low-dose ketoconazole therapy, and such adrenal insufficiency may have a prolonged course.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3826130     DOI: 10.1016/0002-9343(87)90123-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

Review 1.  Adverse drug reactions to systemic antifungals. Prevention and management.

Authors:  J R Perfect; M H Lindsay; R H Drew
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

2.  Effects of ciprofloxacin on testosterone and cortisol concentrations in healthy males.

Authors:  N M Waite; D J Edwards; W S Arnott; L H Warbasse
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

Review 3.  Overview of medically important antifungal azole derivatives.

Authors:  R A Fromtling
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

4.  Ketoconazole-induced transient hypoadrenocorticism in a dog.

Authors:  Alyssa M Sullivant; Patty Lathan
Journal:  Can Vet J       Date:  2020-04       Impact factor: 1.008

5.  Adrenocortical function: an indicator of severity of disease and survival in chronic critically ill patients.

Authors:  L F Span; A R Hermus; A K Bartelink; A J Hoitsma; J S Gimbrère; A G Smals; P W Kloppenborg
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 6.  New antifungal agents for the systemic mycoses.

Authors:  S M Ringel
Journal:  Mycopathologia       Date:  1990-02       Impact factor: 2.574

Review 7.  Treatment of systemic fungal infections: recent progress and current problems.

Authors:  T J Walsh; A Pizzo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

8.  Bicalutamide and third-generation aromatase inhibitors in testotoxicosis.

Authors:  Anne M Lenz; Dorothy Shulman; Erica A Eugster; Samar Rahhal; John S Fuqua; Ora H Pescovitz; Katherine A Lewis
Journal:  Pediatrics       Date:  2010-08-16       Impact factor: 7.124

Review 9.  The treatment of advanced prostate cancer with ketoconazole: safety issues.

Authors:  R A Bok; E J Small
Journal:  Drug Saf       Date:  1999-05       Impact factor: 5.228

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.